Carton Zol
Zoledronic Acid Injection
Product Images NDC 68083-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zoledronic Structure (Zoledronic 01)
Image 2 (Zoledronic 02)
The text refers to a chart or a graph, which shows the proportion of complete responders in pooled studies of HCM. It compares the percentage of complete responders at day 10 of treatment with Zoledronic acid injection 4 mg and Pamidronate 90 mg. The data shows that on day 10, the percentage of complete responders was higher for Zoledronic acid injection 4 mg compared to Pamidronate 90 mg. A P value of 0.002 suggests a statistical significance difference.*
Zoledronic Bottle Label
This is a pharmaceutical product for intravenous infusion, with the active ingredient Zoledronic Acid. It is available in a 100mL bottle and should be stored between 15°C to 30°C. The infusion time should not be less than 15 minutes and the package insert should be consulted for dosage information. It is a sterile solution that should not be mixed with calcium-containing solutions and should be administered through a separate vented infusion line. It is single-dose, and any unused portion should be discarded. The manufacturer is Gland Pharma Limited, located in Hyderabad, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
